Common use

Letairis (ambrisentan) is a prescription medication used to treat pulmonary arterial hypertension (PAH) in adults. As an endothelin receptor antagonist (ERA), Letairis works by blocking the effects of endothelin-1, a naturally occurring substance that causes blood vessels in the lungs to constrict and narrow. By inhibiting this process, ambrisentan helps relax and widen the pulmonary arteries, improving blood flow through the lungs and reducing the strain on the right side of the heart. Patients who buy Letairis online typically seek it for its proven ability to improve exercise capacity, reduce symptoms of breathlessness, and slow the progression of PAH. Clinical studies have demonstrated that ambrisentan significantly improves the six-minute walk distance, a key measure of functional ability in PAH patients. Letairis belongs to the class of pulmonary vasodilators and is often used as part of a comprehensive treatment plan for managing this serious cardiovascular condition.

Dosage and direction

Letairis is taken orally once daily, with or without food. Tablets should be swallowed whole with a glass of water and must not be crushed, split, or chewed. The usual starting dose of ambrisentan is 5 mg once daily, which may be increased to 10 mg once daily based on your doctor's assessment of tolerability and clinical response. Your healthcare provider will individualize your dosage based on liver function tests, hemoglobin levels, and other relevant health parameters. Regular monitoring of liver enzymes, blood counts, and fluid retention is essential throughout treatment. It is important to take Letairis at the same time each day to maintain consistent blood levels of the medication.

Precautions

Before starting Letairis, inform your doctor about any pre-existing medical conditions, particularly liver disease, heart failure, low blood pressure, or a history of anemia. Ambrisentan carries a serious risk of birth defects and is strictly contraindicated in pregnancy. Women of childbearing age must use reliable contraception and undergo monthly pregnancy tests while taking this medication. Patients should be monitored regularly for signs of peripheral edema (swelling in the legs or ankles), dizziness, lightheadedness, or jaundice (yellowing of the skin or eyes). Letairis may cause a decrease in hemoglobin and hematocrit levels, so periodic blood tests are necessary. Report any unexplained fatigue, unusual bruising, or shortness of breath to your healthcare provider promptly.

Contraindications

Do not use Letairis if you are allergic to ambrisentan or any inactive ingredient in the tablet formulation. Letairis is absolutely contraindicated during pregnancy due to its teratogenic effects and potential to cause severe birth defects. Patients with idiopathic pulmonary fibrosis (IPF) should not take ambrisentan, as clinical trials showed no benefit and increased risk of fluid retention and hospitalization. Severe hepatic impairment is also a contraindication for this endothelin receptor antagonist medication.

Possible side effect

Common side effects of Letairis include peripheral edema (swelling in the legs or ankles), nasal congestion or sinusitis, flushing, headache, palpitations, and fatigue. Some patients may also experience nausea, abdominal pain, or constipation. More serious side effects requiring immediate medical attention include signs of liver toxicity (such as dark urine, persistent nausea, upper right abdominal pain, or jaundice), significant anemia with symptoms of weakness and pale skin, severe fluid retention, or allergic reactions including rash, hives, and difficulty breathing. Contact your doctor immediately if you experience any of these serious adverse effects while taking ambrisentan.

Drug interaction

Letairis may interact with several medications, and it is essential to inform your doctor of all drugs you are taking. Cyclosporine can significantly increase ambrisentan blood levels, potentially requiring dose adjustment. Rifampin and other strong enzyme inducers may alter the effectiveness of Letairis. Use caution when combining ambrisentan with other vasodilators or blood pressure-lowering medications, as this may enhance the risk of hypotension. Inform your healthcare provider about all prescription drugs, over-the-counter products, herbal remedies, and dietary supplements you are currently using.

Missed dose

If you miss a dose of Letairis, take it as soon as you remember on the same day. If it is already near the time of your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for the one you missed, as this may increase the risk of side effects.

Overdose

An overdose of Letairis may cause severe hypotension (dangerously low blood pressure), pronounced dizziness, fainting, headache, or signs of liver dysfunction. If you suspect an overdose of ambrisentan, seek immediate emergency medical attention. There is no specific antidote, and treatment is supportive, focusing on maintaining blood pressure and monitoring liver function.

Storage

Store Letairis tablets at controlled room temperature between 20 and 25 degrees Celsius (68 to 77 degrees Fahrenheit), away from excessive heat, moisture, and direct light. Keep tablets in their original container with the lid tightly closed. Store out of reach of children and pets. Do not use Letairis after the expiration date printed on the packaging.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.